This is the authors' abstract. We don't add key points for this paper.
This study shows that firms in the pharmaceutical industry experience decreasing returns to scale in R & D as the level of R & D expenditures rises. The paper presents the results of our study of the innovative output of 16 pharmaceutical firms over a 19 year period. Given the strong correlation between R & D budgets and firm size, our study suggests the wave of mergers in the industry may yield less innovative productivity than managers expect.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Graves et al. (1993) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: